Teclison - Crunchbase Company Profile & Funding

Q: Where is Teclison's headquarters?

Teclison is located in Montclair, New Jersey, United States.

Q: Who invested in Teclison?

Teclison has 2 investors including Nestor Capital And WTT Investment.

Q: When was the last funding round for Teclison?

Teclison closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Teclison raised to date?

Teclison has raised obfuscated.

Overview

Teclison

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Teclison

CB Rank

98569

Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.

Founded

obfuscation

Private

Venture - Series Unknown

Montclair, New Jersey, United States

1-10

teclison.com/

Biotechnology

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Ray Lee: Founder and Chief Medical Officer
Past Role: Roche, Senior Director and Translation Medicine Leader
Wan Lung Eng: Chief Financial Officer
Past Role: Spectral AI, Chief Financial Officer

Details

Legal Name

Teclison Ltd.

Operating Status

Active

Company Type

For Profit

Founders

Ray Lee

About the Company

Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.

Contact Email

info@teclison.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

TEC-001 with transarterial embolization (TATE)

A cancer treatment combining transarterial embolization to induce tumor hypoxia with immune checkpoint inhibitors to generate systemic anticancer immune responses.

TEC-002

A therapy that induces tumor cell death and presents tumor antigens to activate the immune system against solid tumors.

Research & Development

Teclison is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Teclison	2	obfuscated obfuscation	WTT Investment	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Teclison	2	obfuscated obfuscation	WTT Investment	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Teclison	2	obfuscated obfuscation	WTT Investment	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Teclison	2	obfuscated obfuscation	WTT Investment	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Teclison	2	obfuscated obfuscation	WTT Investment	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Teclison	2	obfuscated obfuscation	WTT Investment	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Teclison	2	obfuscated obfuscation	WTT Investment	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Teclison	2	obfuscated obfuscation	WTT Investment	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Teclison	2	obfuscated obfuscation	WTT Investment	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Teclison	2	obfuscated obfuscation	WTT Investment	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Nestor Capital	—	Venture Round - Teclison	—
Nestor Capital	—	Venture Round - Teclison	—
Nestor Capital	—	Venture Round - Teclison	—
Nestor Capital	—	Venture Round - Teclison	—
Nestor Capital	—	Venture Round - Teclison	—